Navigation Links
M2S Expert gives address "Applying the Principles of Six Sigma in the Imaging Core Lab" at Imaging for Clinical Trials conference
Date:2/17/2009

M2S Expert Dr. Steven Marra will give the featured address entitled "Applying the Principles of Six Sigma in the Imaging Core Lab" at the Center for Business Intelligence (CBI) 6th Annual Imaging for Clinical Trials conference. Dr. Marra's presentation will examine how the application of Lean Six Sigma principles have contributed to the development of the company's highly efficient image management processes and workflow, and the resulting benefit to clinical trials sponsors utilizing the service.

(PRWEB) February 17, 2009 -- M2S Inc., a global provider of image management services for biopharmaceutical and medical device clinical trials, announced today that Steven Marra, Ph.D., Senior Research & Design Engineer at M2S, Inc. will give the featured address entitled "Applying the Principles of Six Sigma in the Imaging Core Lab" at CBI's 6th Annual Imaging for Clinical Trials on February 26-27, 2009 in Vienna, VA.

"This presentation will introduce the basic principles of Lean and Six Sigma, and show attendees how the application of these principles has improved the quality and efficiency of our core lab business and helped us streamline our processes. Not only does M2S benefit from these process improvements, but so do our customers through faster turnaround, outstanding quality and lower costs," said Dr. Marra.

Dr. Steve Marra currently holds the position of Senior Research and Design Engineer at M2S, Inc. He received his B.S. in mechanical engineering from the University of Pittsburgh, and his M.S. and Ph.D. degrees in mechanical engineering from the Johns Hopkins University. Dr. Marra was then jointly employed in a post-doctoral position by the Dartmouth College Thayer School of Engineering and by the Dartmouth-Hitchcock Medical Center Section of Vascular Surgery. He began working at M2S in March of 2007, and is currently involved in image analysis tool development and validation, process engineering, and new research projects.

About M2S, Inc.

M2S provides image and data management services for clinical trials sponsors in the biopharmaceutical and medical device industries, patient registry databases and is a recognized leader in 3-D endovascular treatment planning. On December 31, 2008 M2S acquired DXA Resource Group (DRG), a clinical trials service company focused on providing customer-centric, cost-effective quality assurance as well as data and project management for clinical trials involving DXA measurements. For the past 10 years, M2S has managed, under protocol, millions of images from around the globe in various therapeutic areas and in all DICOM modalities. For more information, visit www.m2s.com.

# # #

Read the full story at http://www.prweb.com/releases/clinical/trials/prweb2042344.htm.


'/>"/>
Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved  

Related biology technology :

1. Free DXA Bone Mineral Density and Body Composition in Clinical Trials Webinars to be Held by M2S DXA Division Expert
2. Dr. Ricky Takai, Expert in Designing and Managing Federal Evaluation Studies in Education, Joins Abt Associates
3. African Ancestry, Educators, Identity Experts Launch DNA Education Project during Historic Black History Month; 7th Graders Score High on Ultimate Self Test
4. Free DXA Bone Mineral Density and Body Composition in Clinical Trials Webinars to be Held by M2S DXA Division Expert
5. Valerie DeFillipo, Reproductive Health and Rights Expert, Joins Abt Associates
6. Dr. John Stephen Osika, HIV/AIDS and Infectious Disease Expert, Joins Abt Associates
7. Experts argue nano food-additives require new oversight
8. Hawaii LASIK Eye Surgery Expert Dr. John D. Olkowski Qualifies and Lists with Trusted LASIK Surgeons
9. Top LASIK and Refractive Experts in Trusted LASIK Surgeons Directory Present Research and Educate Their Peers at Annual AAO Meeting in Atlanta
10. Houston LASIK Eye Surgery Expert and Pioneer Jack Holladay, M.D. Joins Influential Group of Eye Surgeons Listed at Trusted LASIK Surgeons
11. New Report Provides Expert Analysis of Recent Advances and Setbacks in Parkinsons Disease Drug Development
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
M2S Expert gives address "Applying the Principles of Six Sigma in the Imaging Core Lab" at Imaging for Clinical Trials conference
(Date:1/19/2017)... ... January 19, 2017 , ... ... the full spectrum of drug and device development, and Prism Clinical Research ... and clinicians, today announced Verified Clinical Trials (VCT) has been selected ...
(Date:1/19/2017)... Jan. 18, 2017 Acupath Laboratories, Inc., a ... formation of an Executive Committee that will guide the ... John Cucci , a 15-year veteran of ... of Business Development to Chief Sales Officer .  ... served in senior sales leadership roles at several leading ...
(Date:1/18/2017)... According to a new market research report "In situ ... & End User (Molecular Diagnostic Laboratories, Academic and Research Institutions) - Global Forecast ... Million by 2021 from USD 557.1 Million in 2016, growing at a CAGR ... ... MarketsandMarkets Logo ...
(Date:1/18/2017)... , Jan. 18, 2017   Parent Project Muscular ... to end Duchenne muscular dystrophy (Duchenne) , today ... New Jersey Institute of Technology (NJIT) and Talem Technologies ... of robotic technology to assist people living with ... NJIT,s technology – an embedded computer, software, a force ...
Breaking Biology Technology:
(Date:12/20/2016)... 2016   Valencell , the leading innovator ... STMicroelectronics (NYSE: STM), a global semiconductor leader serving ... today the launch of a new, highly accurate ... includes ST,s compact SensorTile turnkey multi-sensor ... sensor system. Together, SensorTile and Benchmark deliver the ...
(Date:12/16/2016)... 2016 Research and Markets has announced the ... Forecast to 2021" report to their offering. ... The biometric vehicle access system ... CAGR of 14.06% from 2016 to 2021. The market is estimated ... reach 854.8 Million by 2021. The growth of the biometric vehicle ...
(Date:12/15/2016)... , Dec. 15, 2016   WaferGen Bio-systems, Inc. ... genomics technology company, announced today that on December 13, ... Department of The Nasdaq Stock Market LLC which acknowledged ... price of WaferGen,s common stock had been at $1.00 ... has regained compliance with Listing Rule 5550(a)(2) of the ...
Breaking Biology News(10 mins):